GENE ONLINE|News &
Opinion
Blog

Fecal Microbiota Transplantation
GeneOnline’s Pick: Top 10 Industry News Stories in 2022
2022-12-26
Rebyota Passes Through FDA To Become First Approved Fecal Microbiota Product
2022-12-05
OpenBiome and the University of Minnesota collaborate to give Microbes to those in Need
2022-01-26
Australia’s BiomeBank Seeks Approval for the World’s First Microbial Therapy
2021-07-04
The Influential Role of Gut Microbiome in Cancer Therapy
2020-08-06Partner
Gearing Towards a Microbiome Driven Therapy for Fighting Inflammatory Diseases
2020-03-20
Highlights in the 4th Asia Microbiome Conference: Trends in the microbial industry, top ten global trends in gastrointestinal microbiota, non-bacterial microbiota in colorectal cancer, and second-generation probiotic
2020-01-22Partner
Combating Clostridium difficile infections using Fecal Microbiota Transplant
2019-12-02
LATEST
Healthcare+ Expo Taiwan 2024 To Become A Global Trade Fair With 600+ Companies Attending
2024-11-29
Cracking the Code: How Genetics Shapes Strength, Power, and Speed in Sports
2024-11-27
Shared Expertise, Shared Vision: Biotech Powerhouses Drive Innovation in This Billion-Dollar Market
2024-11-27
MIRDC Hosts Seminar Featuring Diverse Applications of Plasma Sterilization Technology
2024-11-26
How Minaris is Tackling the Scalability Challenge in Cell and Gene Therapy: A Conversation with CEO, Dr. Hiroto Bando
2024-11-26
PuriBlood Breaks into Brazil: Partners with ABHH and Cromo to Conquer Latin America’s Largest Blood Market
2024-11-26
Merck’s Multi-Billion-Dollar KEYTRUDA Levels Up with Novel Subcutaneous Delivery, Matching IV Efficacy
2024-11-22
EVENT
2024-12-05
8th Healthcare Expo Taiwan
Taipei, Taiwan
Scroll to Top